|
Market Closed -
Toronto S.E.
21:00:00 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.870 CAD | -0.51% |
|
-3.73% | -19.71% |
| 09-24 | HLS Therapeutics Gets TSX Acceptance to Increase Normal Course Issuer Bid | MT |
| 08-12 | HLS Therapeutics Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Chart: Technical Analysis
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| HLS | Delayed | |
OTC Markets
| HLTRF | Delayed | |
|
Deutsche Boerse AG
| 74D | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 4.2 | 4.71 | 4.59 |
| Spread/Res. | -7.86% | -17.83% | -15.69% |
| Spread/Supp. | +7.50% | +7.50% | +4.59% |
| Support | 3.6 | 3.6 | 3.7 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- HLS Stock
- Charts HLS Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
